IGFBP2 and central nervous system cancer: Recent studies in glioma implicate IGFBP2 in the activation of PI3K Akt pathway [28], integrin/ILK/NF-B network which drives glioma progression in mice [29] and binding to integrin α5 [30] that brings about increased migration and invasion.